Inspire Medical Systems, Inc.

Stage 2 · Advancing · week 4

As of Oct 22, 2026, Inspire Medical Systems is in Stage 2, the uptrend phase, now in week 4 (since Sep 30, 2026). It closed at $72.66, 49.5% below its 52-week high and above its 200-day average, which is falling.

$72.66

+2.24% today

$2.1B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is INSP early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 15w

S1 16w

S3 17w

S4 35w

S4 24w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 4w → S4 15w → S1 16w → S2 5w → S3 4w → S4 7w → S1 7w → S2 7w → S3 17w → S4 35w → S1 10w → S4 24w → S1 9w → S2 3w current

Total tracked: 165 weeks across 14 stage runs.

INSP among Medical Devices57th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…57	INSPInspire Medical Systems, Inc.	Stage 2 · wk 4	45	+5.2%

vs 52W High

-49.5%

$40.05 lo$143.99 hi

49.5% below 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 4

1w13w26w

Week 4, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

22.5%

200 DMA: $59.33 · sloping down

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.86x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+5.2%

+47.7%

+28.9%

YTD

-21.3%

-12.2%

Scan Membership

Breakout Watch

Latest: 2024-10-03

10 appearances in last 60 days. First seen: 2019-02-19.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 4 · Vol 0.86x

2026-10-21S2

Wk 4 · Vol 0.31x

2026-10-20S2

Wk 3 · Vol 1.39x

2026-10-19S2

Wk 3 · Vol 0.87x

2026-10-16S2

Wk 3 · Vol 0.65x

2026-10-15S2

Wk 3 · Vol 0.80x

2026-10-14S2

Wk 3 · Vol 1.06x

2026-10-13S2

Wk 2 · Vol 1.29x

2026-10-12S2

Wk 2 · Vol 1.27x

2026-10-09S2

Wk 2 · Vol 1.09x

2026-10-08S2

Wk 2 · Vol 1.06x

2026-10-07S2

Wk 2 · Vol 1.89x

Moving averages & range

50 DMA

$67.18

200 DMA

$59.33

52W High

$143.99

52W Low

$40.05

5D Low

$68.79

Resistance levels (recent highs)

20d High

$73.18

60d High

$76.78

120d High

$76.78

250d High

$143.99

Next resistance

+0.7%

to 20d High

P/E (TTM)

16.0

Forward 47.3

ROE

+18.0%

Profit margin +15.0%

Dividend Yield

0.00%

P/B 2.5

Inspire Medical Systems: quick answers

What stage is Inspire Medical Systems in?

As of Oct 22, 2026, Inspire Medical Systems (INSP) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 30, 2026 and is in week 4. What the four stages mean

Is Inspire Medical Systems in an uptrend?

Yes. Inspire Medical Systems is in a Stage 2 uptrend. It trades 22.5% above its 200-day average, which is falling.

How far is Inspire Medical Systems from its 52-week high?

Inspire Medical Systems closed at $72.66 on Oct 22, 2026, 49.5% below its 52-week high of $143.99. Its 52-week low is $40.05.

How has Inspire Medical Systems performed over the past year?

As of Oct 22, 2026, Inspire Medical Systems is down 12.2% over the past year and down 21.3% so far in 2026.

Which sector and industry is Inspire Medical Systems in?

Inspire Medical Systems is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.